Bluechiip Limited Stock Market Press Releases and Company Profile
Major Agreement Signed With Labcon North America
Major Agreement Signed With Labcon North America

Melbourne, April 10, 2017 AEST (ABN Newswire) - Bluechiip Limited (googlechartASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced it has entered a license and supply agreement with California-based Labcon North America (Labcon), the world's leading manufacturer of earthfriendly laboratory consumables.

Key points:

- Bluechiip enters third major supply and license agreement - the first in North America.

- Technology access fee with upfront and ongoing fees over the next 18 months.

Last year, Labcon molded over 1.4 billion products for major companies in the life sciences sector, including centrifuge tubes, pipet tips, microbiology disposables, organization tools, and a wide range of OEM/specialty items.

This agreement allows Labcon to buy, utilize, sell, market and promote Bluechiip's IP, technology and products. Labcon has undertaken full technical and business due diligence and has identified customers to proceed with pilot programs of Bluechiip-integrated products in the near term.

Jim Happ, Labcon President, said: "This partnership, and the advanced technology it provides, allows us to differentiate our products and provide a series of value-added solutions for latent customer needs that no other technology available can solve. We are looking forward to integrating the Bluechiip technology into a collection of data-enabled products that we can sell across multiple customer segments."

Andrew McLellan, Managing Director of Bluechiip Limited, said: "This OEM partnership agreement is pivotal for Bluechiip. It is our first in North America, our primary target market. Our relationship with Labcon started last year with their purchase of a starter kit, which they tested extensively. In this new OEM agreement Labcon will buy an initial series of our multivial readers, MEMS chips and Stream software to use in customer trials. Volume will build from there. This agreement represents an important inroad into high-value markets.

"We have been working on a number of customer leads with Labcon over the past six months and are excited about the opportunities presented by this major consumables manufacturer and the access to major supply chains this agreement provides.

About Labcon North America:

Labcon North America is the world's leading producer of low carbon laboratory disposables and was the first to market bioplastics for laboratories. Labcon's focus on sustainable solutions for laboratories dates to 1994 with the first low carbon products. A UL-Certified ISO 9001:2008 company; Labcon North America is headquartered in the San Francisco Bay area.

Further information is available at: http://www.labcon.com/


About Bluechiip Limited

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

https://twitter.com/bluechiip https://www.youtube.com/channel/UCaVcyO4O2oJ_9fLdMs6JIyQ https://www.linkedin.com/company/bluechiip-limited abnnewswire.com 


Contact

Corporate enquiries
Andrew McLellan
Managing Director - CEO
Ph: +61-457-823-470
andrew.mclellan@bluechiip.com

Media
Richard Allen
Ph: +61-3-9915-6341
Oxygen Financial PR
richard@oxygenpr.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 8) (Last 30 Days: 34) (Since Published: 3260)